Invigorate Biotechnologies is Technology-driven cell and gene therapy company.
Founded in 2022 by a group of passionate synthetic biotechnologists with decades of industry experience in the field of Biotechnology and a proven track record of delivering cost-effective solutions. Invigorate Biotechnologies was incorporated with a single mission in mind: to empower scientific discoveries by providing access to the world’s most advanced biotech Products.
Invigorate Bio is a values-based company, deeply rooted in science and innovation to transform new ideas to discoveries, As a Technology-driven company, we are using advanced gene engineering to change how disease are treated.
“Driven by Science & discovery”
The core strength of company comes from passionate, innovative, and nimble, results-oriented people driven by science to develop better options for patients with cancer and genetic diseases.
We are made up of talented teams and individuals who significantly impact both our own business and the communities in which we operate. Global partners and clients are advantageous to our business. However, we have made an effort to keep our flexibility so that we can respond to local market needs.
Leadership
We are a highly experienced and proven management team that has delivered multiple, impactful biological products and technologies in the market. The organization is comprised of passionate, innovative, and nimble, results-oriented people driven by science to develop better options for patients with cancer and genetic diseases.
Board of Directors
The Board of Directors establishes the strategic direction for overall Invigorate Biotechnologies LLP management, and is in charge of supervising the individuals with Group management. It is in charge of giving all necessary instructions, particularly those that pertain to following the law, the articles of association, and all applicable rules and directives. The Board of Directors pledges to uphold the highest levels of integrity and transparency in managing Invigorate Biotechnologies LLP.
Jainendra Jain, Director
Davender Kumar Bhati, Director
0
/5
Rating from Over 2.5k Beneficiaries
0
Tests Completed Rapidly and Precisely
0
%
Accurate and Precise in Test Results
The most competitive and
productive service
Mission Statement
Provide a safe, supportive environment focused on healing, prevention and wellness.
Vision Statement
We lead in the creation and delivery of services that enable our clients to win in the changing world of work.
Our Commitment
We are always committed towards delivering excellence
Our Aim
Our aim is to develop a safe, efficacious and cost-effective gene delivery system based on established Lentivirus vector platforms, which are scalable and can be accommodated into a multi-product manufacturing facility with lower biosafety requirements.
Market
Cell and gene therapy is a fast-growing market with increasingly growing candidates in the pipeline. We can enable CGT discovery and development workflows with innovative solutions, including services, and subject matter expertise.
Our Ecosystem
Ecosystem of technologies and capabilities enables us to discover, develop, manufacture, and commercialize an unprecedented, broad spectrum of cell and gene therapies and regenerative medicines. Our approach enables a sharp focus on differentiated technologies and R&D efforts, while simultaneously removing barriers to knowledge and new scientific breakthroughs.
In all aspects of business, Invigorate Biotechnologies LLP maintains a system of well-established policies and procedures. From strategic support activities like finance, human resources, and regulatory affairs to core operations like research and technology development. We continuously work to integrate the entire organisation. In order to monitor statutory and operational issues, the internal audit function is further reinforced in co-operation with statutory auditors.